Christine M. Barbon

626 total citations
15 papers, 428 citations indexed

About

Christine M. Barbon is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Christine M. Barbon has authored 15 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Christine M. Barbon's work include T-cell and B-cell Immunology (4 papers), Lysosomal Storage Disorders Research (4 papers) and Adenosine and Purinergic Signaling (3 papers). Christine M. Barbon is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Lysosomal Storage Disorders Research (4 papers) and Adenosine and Purinergic Signaling (3 papers). Christine M. Barbon collaborates with scholars based in United States and United Kingdom. Christine M. Barbon's co-authors include Seng H. Cheng, Robin J. Ziegler, Chester Li, Robert J. Desnick, Donna Armentano, Maribeth Cherry, Eva C. Guinan, Annie Voskertchian, Jeff Davies and Lee M. Nadler and has published in prestigious journals such as Cancer Research, Science Translational Medicine and Vaccine.

In The Last Decade

Christine M. Barbon

15 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine M. Barbon United States 9 164 136 115 112 97 15 428
Elisa Masat Italy 10 233 1.4× 96 0.7× 216 1.9× 92 0.8× 100 1.0× 12 465
Luc‐Marie Gerland France 6 185 1.1× 95 0.7× 35 0.3× 125 1.1× 122 1.3× 11 443
Ann Mary United States 11 163 1.0× 47 0.3× 90 0.8× 92 0.8× 74 0.8× 19 449
Chester Li United States 7 149 0.9× 161 1.2× 140 1.2× 22 0.2× 103 1.1× 8 320
Kamel Chettab France 14 180 1.1× 42 0.3× 58 0.5× 81 0.7× 56 0.6× 31 479
Maribeth Cherry United States 7 263 1.6× 162 1.2× 208 1.8× 34 0.3× 124 1.3× 7 446
Elisa Adele Colombo Italy 11 263 1.6× 37 0.3× 122 1.1× 83 0.7× 84 0.9× 36 535
Nora Naumann United States 9 190 1.2× 48 0.4× 176 1.5× 272 2.4× 32 0.3× 13 462
Sarah Roord Netherlands 12 194 1.2× 36 0.3× 55 0.5× 363 3.2× 72 0.7× 16 607
Philip Marsh United Kingdom 12 218 1.3× 77 0.6× 67 0.6× 266 2.4× 47 0.5× 21 615

Countries citing papers authored by Christine M. Barbon

Since Specialization
Citations

This map shows the geographic impact of Christine M. Barbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine M. Barbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine M. Barbon more than expected).

Fields of papers citing papers by Christine M. Barbon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine M. Barbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine M. Barbon. The network helps show where Christine M. Barbon may publish in the future.

Co-authorship network of co-authors of Christine M. Barbon

This figure shows the co-authorship network connecting the top 25 collaborators of Christine M. Barbon. A scholar is included among the top collaborators of Christine M. Barbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine M. Barbon. Christine M. Barbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chandra, Dinesh, Christine M. Barbon, Alexandra Borodovsky, et al.. (2020). Abstract A87: The A2AR antagonist AZD4635 prevents adenosine-mediated immunosuppression in tumor microenvironment and enhances antitumor immunity partly by enhancing CD103+ dendritic cells. Cancer Immunology Research. 8(3_Supplement). A87–A87. 2 indexed citations
2.
3.
Barbon, Christine M., Alexandra Borodovsky, Yanjun Wang, et al.. (2019). Abstract LB-192: The A2AR antagonist AZD4635 prevents adenosine-mediated immunosuppression of CD103+ dendritic cells. Cancer Research. 79(13_Supplement). LB–192. 3 indexed citations
4.
Yang, Jun, Norma C. Serrano, Joseph W. Adelsberger, et al.. (2016). The effects of storage temperature on PBMC gene expression. BMC Immunology. 17(1). 6–6. 60 indexed citations
5.
Barbon, Christine M., et al.. (2014). Alloanergization of Human T Cells Results in Expansion of Alloantigen-Specific CD8+CD28− Suppressor Cells. American Journal of Transplantation. 14(2). 305–318. 26 indexed citations
6.
Davies, Jeff, Christine M. Barbon, Annie Voskertchian, Lee M. Nadler, & Eva C. Guinan. (2012). Ex Vivo Alloanergization with Belatacept: A Strategy to Selectively Modulate Alloresponses after Transplantation. Cell Transplantation. 21(9). 2047–2061. 19 indexed citations
8.
Davies, Jeff, Christine M. Barbon, Annie Voskertchian, Lee M. Nadler, & Eva C. Guinan. (2011). Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade. Journal of Visualized Experiments. 8 indexed citations
9.
Guinan, Eva C., Christine M. Barbon, Leslie A. Kalish, et al.. (2011). Bactericidal/Permeability-Increasing Protein (rBPI 21 ) and Fluoroquinolone Mitigate Radiation-Induced Bone Marrow Aplasia and Death. Science Translational Medicine. 3(110). 110ra118–110ra118. 30 indexed citations
10.
Barbon, Christine M., et al.. (2010). Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization. Cellular Immunology. 262(2). 150–161. 34 indexed citations
11.
Barbon, Christine M., et al.. (2010). In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization. Vaccine. 28(50). 7852–7864. 14 indexed citations
12.
Ziegler, Robin J., Claire Brown, Christine M. Barbon, et al.. (2009). Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann–Pick disease. Molecular Genetics and Metabolism. 97(1). 35–42. 8 indexed citations
13.
Ziegler, Robin J., Maribeth Cherry, Christine M. Barbon, et al.. (2006). Correction of the Biochemical and Functional Deficits in Fabry Mice Following AAV8–mediated Hepatic Expression of α-galactosidase A. Molecular Therapy. 15(3). 492–500. 73 indexed citations
14.
Barbon, Christine M., Robin J. Ziegler, Chester Li, et al.. (2005). AAV8-Mediated Hepatic Expression of Acid Sphingomyelinase Corrects the Metabolic Defect in the Visceral Organs of a Mouse Model of Niemann–Pick Disease. Molecular Therapy. 12(3). 431–440. 34 indexed citations
15.
Ziegler, Robin J., Scott Lonning, Donna Armentano, et al.. (2003). AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice. Molecular Therapy. 9(2). 231–240. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026